Biocept is using a simple non-invasive blood test, sometimes referred to as a liquid biopsy, to help doctors and patients create more personalized, responsive treatment plans by tracking cancer in real time.
How can a simple blood test help you and your doctor in the fight against cancer?
The Science Behind Liquid Biopsy
Cancer at any stage can shed tumor cells as well as fragments of cancer-causing DNA into the blood system. The more advanced the cancer, the more likely tumor cells and cancer-causing DNA can be found in the blood.
Biocept technology is uniquely designed with analytically and clinically validated reagents to detect tumor cells and cancer-causing DNA from a patient’s blood sample. All tests performed in our CLIA-certified, CAP-accredited laboratory have undergone appropriate validation.
Biocept has developed the most advanced methods for finding cancer cells and DNA fragments in the blood.
You and your doctor get the same information you would get from an invasive tissue biopsy—all from a simple blood test.
And because Biocept uses blood, our tests inform your doctor on what’s happening with your cancer NOW—not weeks, months, or years ago.
Who should consider a liquid biopsy?
When cancer spreads, it sometimes changes—and a biopsy taken from the original tumor may not give your doctor all the information needed for appropriate treatment. A liquid biopsy gives you and your doctor a more complete understanding of metastatic cancer.
You may be a good candidate for a liquid biopsy if:
How does it work?
A liquid biopsy from Biocept provides a fast, easy way to establish cancer biomarker status.
Get a blood test.
You can have your blood drawn the same day your doctor orders the test.
The sample is sent to Biocept’s laboratory.
Your physician should receive the results of your test in approximately 5-7 days from when Biocept receives your sample.
Your physician gets your results.
Results are intended to provide information to your doctor about the presence of certain cancer-associated biomarkers found in circulating tumor cells (CTCs) and/or circulating tumor DNA (ctDNA) in the blood. These results can assist your doctor in understanding the status of your disease to make decisions about current and future therapy.